TaiMed Biologics (4147) — Strategic Asset Allocation Index
TaiMed Biologics (4147) has a Strategic Asset Allocation Index of 35.1% as of June 2023. Strategic assets (PP&E of NT$930.02 Million plus long-term investments of NT$-) total NT$930.02 Million, measured against net assets of NT$2.65 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check TaiMed Biologics (4147) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
TaiMed Biologics Strategic Asset Allocation Index (2009–2022)
This chart shows how TaiMed Biologics's Strategic Asset Allocation Index has evolved across 14 annual periods from 2009 to 2022. As of June 2023, the index stands at 35.1%, representing strategic assets of NT$930.02 Million against net assets of NT$2.65 Billion TWD. See TaiMed Biologics (4147) flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for TaiMed Biologics (2009–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for TaiMed Biologics from 2009 to 2022, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see TaiMed Biologics stock valuation.
| Year | SAAI | Strategic Assets (TWD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 35.3% | NT$957.74 Million | NT$957.74 Million | NT$- | NT$2.71 Billion | ▲ +0.9 pp |
| 2021 | 34.4% | NT$1.01 Billion | NT$1.01 Billion | NT$- | NT$2.94 Billion | ▲ +3.2 pp |
| 2020 | 31.2% | NT$1.06 Billion | NT$1.06 Billion | NT$- | NT$3.42 Billion | ▼ -2.0 pp |
| 2019 | 33.2% | NT$1.19 Billion | NT$940.32 Million | NT$249.36 Million | NT$3.59 Billion | ▲ +0.7 pp |
| 2018 | 32.5% | NT$1.33 Billion | NT$863.18 Million | NT$462.53 Million | NT$4.08 Billion | ▲ +21.3 pp |
| 2017 | 11.2% | NT$479.34 Million | NT$315.09 Million | NT$164.25 Million | NT$4.29 Billion | ▲ +10.5 pp |
| 2016 | 0.6% | NT$29.27 Million | NT$19.27 Million | NT$10.00 Million | NT$4.71 Billion | ▲ +0.3 pp |
| 2015 | 0.3% | NT$15.99 Million | NT$15.99 Million | NT$- | NT$4.90 Billion | ▼ -0.6 pp |
| 2014 | 0.9% | NT$16.21 Million | NT$16.21 Million | NT$- | NT$1.83 Billion | ▲ +0.4 pp |
| 2013 | 0.5% | NT$3.17 Million | NT$3.17 Million | NT$- | NT$657.73 Million | ▼ -0.3 pp |
| 2012 | 0.8% | NT$4.84 Million | NT$4.84 Million | NT$- | NT$645.21 Million | ▲ +0.2 pp |
| 2011 | 0.5% | NT$4.25 Million | NT$4.25 Million | NT$- | NT$839.24 Million | ▼ 0.0 pp |
| 2010 | 0.5% | NT$5.45 Million | NT$5.45 Million | NT$- | NT$1.04 Billion | ▼ -0.5 pp |
| 2009 | 1.0% | NT$6.06 Million | NT$6.06 Million | NT$- | NT$598.14 Million | — |